Speciality Medicines Limited (BOM:544738)

Market Cap	1.92B
Revenue (ttm)	582.71M +111.7%
Net Income	71.96M
EPS	11.18
Shares Out	8.79M
PE Ratio	19.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Open	219.00
Previous Close	230.25
Day's Range	218.75 - 220.00
52-Week Range	121.10 - 381.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Speciality Medicines

Speciality Medicines Limited engages in the manufacturing, marketing and distribution of finished formulations of specialty pharmaceutical products in India and internationally. The company offers tablets, capsules, cream, syrups, eye drops, gel, infusion, inhalation, inhaler, injection, nasal spray, ointment, ophthalmic, oral solution, oral suspension, sachet, and suspension for oncology, immunology, neurology, and rare diseases therapeutic areas. It also provides patient, hospitals, institutions and NGO supplies, validated controlled supply m...

• Industry: Pharmaceutical Preparations
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544738

Financial Performance

In fiscal year 2025, Speciality Medicines's revenue was 582.71 million, an increase of 111.71% compared to the previous year's 275.25 million. Earnings were 71.96 million, an increase of 77.62%.